Scar treatment TRTP-101 tracked for Long-Term safety
NCT ID NCT06435884
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study checks the long-term safety and effectiveness of TRTP-101, a treatment for atrophic (depressed) scars. It follows 3 adults who already received TRTP-101 in an earlier study. Researchers will monitor serious side effects and measure changes in scar volume and patient satisfaction over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATROPHIC SCAR are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Samsung Medical Center
Seoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.